Anti-CD248 Therapeutic Antibody (Ontuxizumab)

Recombinant chimeric/humanized hybrid (mouse/human) antibody expressed in CHO binding to human CD248. Ontuxizumab is a monoclonal antibody designed for the treatment of cancer.
Supplier Creative Biolabs
Product # TAB-773
Pricing Inquiry
Host Mouse
Target CD248
Species Reactivity Human
Type IgG1 - kappa
Applications Neut, ELISA, IF, IP, FuncS, FC, ICC
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback